[Scleroderma-like syndrome with bullous morphea during treatment with 5-hydroxytryptophan, carbidopa and flunitrazepam].
Lampert
A
A
Clinique Dermatologique, Hôpital Charles Nicolle, Rouen.
Joly
P
P
Thomine
E
E
Ortoli
J C
JC
Lauret
P
P
D000368:Aged; D002230:Carbidopa / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000139:chemically induced; D005445:Flunitrazepam / Q000009:adverse effects*; D006801:Humans; D008297:Male; D012594:Scleroderma, Localized / Q000139:chemically induced* / Q000473:pathology; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000473:pathology; D014364:Tryptophan / Q000009:adverse effects / Q000031:analogs & derivatives*
D005445:Flunitrazepam; D014364:Tryptophan; D002230:Carbidopa
Syndrome sclérodermiforme à type de morphées bulleuses au cours d'un traitement par 5-hydroxy-tryptophane, carbidopa et flunitrazepam.